Cpd-564

N/A

Report date: 2026/01/14 17:56:08
NME

Base Information

Drug NameCpd-564
Drug Alias NameCpd-564
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionN6-adenosine-methyltransferase catalytic subunit inhibitors
TargetsN6-adenosine-methyltransferase catalytic subunit
Therapy Area/IndicationsAcute Kidney Injury
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesAnhui Medical University
China Registration ClassN/A

Develop Information

Active CompaniesAnhui Medical University
Inactive CompaniesN/A
Active IndicationsAcute Kidney Injury
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A